2Von Mollendorff, Reiff K, Neugebauer G. Pharmacokinetics and bioavability of carvedilol, a vasodilating beta-blocker[J].Eur J Clin Pharmaco1,1987,33:511.
3Cleland JGF, Swedberg K. Carved ilol for heart failure, with care[J]. Lancet,1996,347(9010) :1199.
4Feuerstein GZ, Ruffolo RR. Carvedilol,a novel vasodilating beta-blocker with the potential for cardiovascular organ protection[J], Eur Heart J ,1996,17(Suppl B) :24.
5Yoshikawa T, Port JD, Asono K, et al. Cardiac adrenergic receptor effective of carvedilol[J]. Eur Heart J, 1996,17(SupplB):8.
6Cebeddu LX,Feunmayor N,Varin F,et al. Clinical pharmacology of carvedilol in normal volunteers[J]. Clin Pharmacol Ther,1987,41:31.
7Lahiri A,Rodrigues EA, Al-khawaja L, et al. Effects of a new vasodilating beta-blocking drug, carvedilol on left ventricular function in stable angina pectoris[J]. Am J Cardiol, 1987,59 :769.
8Olsen SL, Gibert EM, Renlund DG, et al. Carvedilol improves left ventricular function in idiopathic dilated cardiomyopathy[J]. Circulation,1991,84(Suppl 1) :564.
9Bril A,Slivjak M,Di M,et al. Cardioprotective effects of carvedilol, a new β-adrenceptor antagonists with vasodilating properties in anesthetized minipigs[J]. Cardiovas Res, 1992,26:515.
10Yue TL, Cheng HY, Lysko P. Carvedilol, a new vasodilater and beta-adrenoceptor antagonists is an antioxidant and free radical scavenger[J]. Pharmacol Exp Ther, 1992,263 : 92.
